(6-150) Clinical Impact of Olezarsen: A Novel ApoC3 Inhibitor for the Management of Familial Chylomicronemia Syndrome and Hypertriglyceridemia

Tuesday, December 9, 2025

10:45 AM - 11:45 AM

Location: Bayside A, Level 1

Pharmacy School: Southwestern Oklahoma State University College of Pharmacy
Pharmacy School Location: Oklahoma

Co-Author(s): Kyle Lacy, Amber Williamson, Jeremy Johnson

Primary Author(s)

Iris Gonzalez, n/a

Student
Southwestern Oklahoma State University College of Pharmacy